X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.biospace.com/article/tg-therapeutics-backpedals-on-lymphoma-leukemia-treatment-drops-applications/
http://www.pharmafile.com/news/606273/fda-investigate-possible-increased-risk-death-lymphoma-medicine
https://finance.yahoo.com/news/tg-therapeutics-falls-30-ceo-173034141.html
https://www.globenewswire.com/news-release/2021/09/23/2302166/8790/en/TG-Therapeutics-Announces-Publication-of-Results-from-an-Integrated-Safety-Analysis-of-UKONIQ-umbralisib-in-Blood-Advances.html
https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-publication-phase-2-data-evaluating
https://www.globenewswire.com/news-release/2020/12/02/2138212/0/en/TG-Therapeutics-Announces-Publication-of-Phase-2-Data-Evaluating-Umbralisib-in-Patients-with-Chronic-Lymphocytic-Leukemia-Who-Are-Intolerant-to-Prior-BTK-or-PI3K-Inhibitor-Therapy-.html
https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-fda-acceptance-new-drug-application
https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-completes-rolling-submission-new-drug
http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-data-presentations-25th-european
https://endpts.com/another-sparse-round-of-nash-data-tg-raises-60m-after-phiii-success/
http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-receives-orphan-drug-designation-umbralisib-us-0
https://www.targetedonc.com/news/umbralisib-developer-seeks-fda-approval-in-marginal-zone-lymphoma-and-follicular-lymphoma
https://www.biospace.com/article/releases/tg-therapeutics-announces-positive-results-from-the-unity-nhl-phase-2b-pivotal-trial-evaluating-umbralisib-monotherapy-in-patients-with-relapsed-refractory-follicular-lymphoma/?s=95
https://globenewswire.com/news-release/2018/09/26/1576423/0/en/TG-Therapeutics-Inc-Announces-Final-Phase-2-Multiple-Sclerosis-Data-Accepted-for-Oral-Presentation-at-the-Upcoming-34th-Congress-of-ECTRIMS.html
https://www.fiercebiotech.com/biotech/tg-stock-sinks-after-setback-to-blood-cancer-trial
https://globenewswire.com/news-release/2018/06/18/1525715/0/en/TG-Therapeutics-Inc-Presents-Phase-2-Data-Evaluating-Umbralisib-in-CLL-Patients-Intolerant-to-Prior-BTK-or-PI3K-Delta-Inhibitor-Therapy-at-the-23rd-Congress-of-the-European-Hematol.html
Market Place
Share 
